Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEAS for Pain in Bone Metastases of Lung Cancer
NCT05730972Not yet recruiting
- Sponsor
- Third Affiliated Hospital of Zhejiang Chinese Medical University
- Start
- Dec 2023
- Primary completion
- Apr 2025
01
Overview
Randomised, double-blind trial (2 arms), sponsored by Third Affiliated Hospital of Zhejiang Chinese Medical University. Primary endpoint: Response rate of average pain in the Brief Pain Inventory (BPI) at 4 weeks. Planned start Dec 2023; status: not yet recruiting.
Beyond the preview
Go deeper on NCT05730972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05730972.